Summary & Overview
CPT 96913: Photochemotherapy, 4–8 Hour Session
CPT code 96913 represents a prolonged photochemotherapy treatment lasting four to eight hours for resistant dermatologic diseases such as psoriasis, eczema, and vitiligo. Nationally, this code captures a specialized, resource-intensive outpatient therapy that combines photosensitizing agents with extended ultraviolet exposure under clinical supervision. Its appropriate use affects access to complex dermatology care and impacts payer coverage policies for prolonged phototherapy services.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for use of 96913, typical sites of service, and the types of conditions for which the service is indicated. The publication also outlines the common modifiers used with the code and provides benchmarking and policy-relevant considerations where available.
This summary equips clinicians, billing staff, and policy analysts with the essential framing of CPT code 96913—what it represents, why it matters in national coverage and utilization discussions, and what to expect when reviewing payer approaches and reimbursement considerations. Data not available in the input: associated taxonomies, specific ICD-10 diagnoses, related codes, and detailed service-line reporting.
Billing Code Overview
CPT code 96913 describes a photochemotherapy session lasting four to eight hours used to treat difficult-to-treat or treatment-resistant dermatologic conditions such as psoriasis, eczema, and vitiligo. The service involves administering systemic or topical photosensitizing agents followed by controlled ultraviolet light exposure to achieve therapeutic skin effects.
-
Service type: Photochemotherapy (long-duration therapeutic phototherapy)
-
Typical site of service: Outpatient dermatology clinic or ambulatory infusion/phototherapy center where prolonged monitored light therapy can be delivered
Clinical & Coding Specifications
Clinical Context
A 45-year-old patient with long-standing, treatment-resistant plaque psoriasis presents to a dermatology clinic after failing multiple topical therapies and systemic agents. The dermatologist has recommended inpatient or outpatient photochemotherapy (psoralen plus ultraviolet A, PUVA) when oral psoralen is administered and the patient undergoes controlled UVA exposure for an extended session of four to eight hours. The clinical workflow includes: pre-treatment evaluation (medical history, ocular exam, current medications), informed consent discussing photosensitizing effects and sun-avoidance, administration of oral psoralen, monitored phototherapy session lasting four to eight hours in a controlled facility, observation for immediate adverse effects, documentation of dose, start/stop times, and any medications or interventions during the session, and scheduling follow-up visits to assess response and monitor cumulative UVA exposure and skin/cancer surveillance. Typical site of service is an outpatient dermatology infusion/phototherapy suite or hospital outpatient department capable of prolonged photochemotherapy monitoring.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default — no modifier | Use when no additional modifier applies |
11 |